Fred Rosche

741 total citations
27 papers, 597 citations indexed

About

Fred Rosche is a scholar working on Oncology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Fred Rosche has authored 27 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Organic Chemistry and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Fred Rosche's work include Peptidase Inhibition and Analysis (11 papers), Diabetes Treatment and Management (8 papers) and Neuropeptides and Animal Physiology (8 papers). Fred Rosche is often cited by papers focused on Peptidase Inhibition and Analysis (11 papers), Diabetes Treatment and Management (8 papers) and Neuropeptides and Animal Physiology (8 papers). Fred Rosche collaborates with scholars based in Germany, Canada and Switzerland. Fred Rosche's co-authors include Hans‐Ulrich Demuth, Raymond A. Pederson, Christopher H.S. McIntosh, Robert P. Pauly, Torsten Hoffmann, Michael Wermann, Hans‐Ulrich Demuth, Susanne Manhart, Francis C. Lynn and Raik Wolf and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

In The Last Decade

Fred Rosche

27 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fred Rosche Germany 12 261 236 202 190 99 27 597
Anders R. Sørensen Denmark 13 215 0.8× 56 0.2× 506 2.5× 36 0.2× 143 1.4× 14 743
Hitoshi Yoshino Japan 13 128 0.5× 33 0.1× 178 0.9× 37 0.2× 173 1.7× 27 528
Stephen E. de Laszlo United States 16 104 0.4× 41 0.2× 394 2.0× 56 0.3× 482 4.9× 28 786
Miaobo Pan China 12 73 0.3× 110 0.5× 227 1.1× 18 0.1× 94 0.9× 20 423
Dieter Hamprecht United Kingdom 19 78 0.3× 32 0.1× 337 1.7× 47 0.2× 616 6.2× 37 961
Satoru Oi Japan 6 81 0.3× 97 0.4× 200 1.0× 46 0.2× 210 2.1× 7 437
Philippe Kahn France 10 25 0.1× 155 0.7× 179 0.9× 107 0.6× 78 0.8× 22 439
R. G. Strachan United Kingdom 11 51 0.2× 78 0.3× 525 2.6× 61 0.3× 275 2.8× 17 707
Jitendra A. Sattigeri India 12 53 0.2× 34 0.1× 136 0.7× 21 0.1× 226 2.3× 30 369
Mihály Szécsi Hungary 18 98 0.4× 45 0.2× 322 1.6× 26 0.1× 337 3.4× 46 664

Countries citing papers authored by Fred Rosche

Since Specialization
Citations

This map shows the geographic impact of Fred Rosche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Rosche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Rosche more than expected).

Fields of papers citing papers by Fred Rosche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Rosche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Rosche. The network helps show where Fred Rosche may publish in the future.

Co-authorship network of co-authors of Fred Rosche

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Rosche. A scholar is included among the top collaborators of Fred Rosche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Rosche. Fred Rosche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosche, Fred, et al.. (2024). Contribution of amino acids in the active site of dipeptidyl peptidase 4 to the catalytic action of the enzyme. PLoS ONE. 19(4). e0289239–e0289239. 2 indexed citations
2.
Eick, Sigrun, et al.. (2020). Controlled release minocycline-lipid-complex extrudates for the therapy of periodontitis with enhanced flexibility. International Journal of Pharmaceutics. 586. 119578–119578. 5 indexed citations
4.
Wagner, Leona, Michael Wermann, Fred Rosche, et al.. (2011). Isolation of dipeptidyl peptidase IV (DP 4) isoforms from porcine kidney by preparative isoelectric focusing to improve crystallization. Biological Chemistry. 392(7). 665–77. 3 indexed citations
5.
Böhme, Livia, et al.. (2008). Isoaspartate residues dramatically influence substrate recognition and turnover by proteases. Biological Chemistry. 389(8). 1043–1053. 25 indexed citations
6.
Rahfeld, Jens‐Ulrich, et al.. (2006). Prolyl Endopeptidase Cleaves the Apoptosis Rescue Peptide Humanin and Exhibits an Unknown Post-Cysteine Cleavage Specificity. Advances in experimental medicine and biology. 575. 103–108. 11 indexed citations
7.
Hinke, Simon A., Francis C. Lynn, Jan A. Ehses, et al.. (2005). Glucose-dependent Insulinotropic Polypeptide (GIP): Development of DP IV-Resistant Analogues with Therapeutic Potential. Kluwer Academic Publishers eBooks. 524. 293–301. 9 indexed citations
8.
Gerhartz, Bernd, et al.. (2005). Characterisation of Human DP IV Produced by a Pichia pastoris Expression System. Kluwer Academic Publishers eBooks. 524. 103–108. 4 indexed citations
9.
Hinke, Simon A., Richard W. Gelling, Susanne Manhart, et al.. (2003). Structure-Activity Relationships of Glucose-Dependent Insulinotropic Polypeptide (GIP). Biological Chemistry. 384(3). 403–7. 17 indexed citations
10.
Rosche, Fred, Jörn Schmidt, Torsten Hoffmann, et al.. (2003). Kinetic Analysis of Enzymatic and Nonenzymatic Degradation of Peptides by MALDI-TOFMS. Humana Press eBooks. 146. 251–272. 1 indexed citations
11.
Raith, Klaus, et al.. (2002). Characterization of Povidone Products by Means of 13C-NMR, MALDI-TOF, and Electrospray Mass Spectrometry. Pharmaceutical Research. 19(4). 556–560. 22 indexed citations
12.
Pospisilik, J. Andrew, Simon A. Hinke, Raymond A. Pederson, et al.. (2001). Metabolism of glucagon by dipeptidyl peptidase IV (CD26). Regulatory Peptides. 96(3). 133–141. 60 indexed citations
13.
Wolf, Raik, Fred Rosche, Torsten Hoffmann, & Hans-Ulrich Demuth. (2001). Immunoprecipitation and liquid chromatographic–mass spectrometric determination of the peptide glucose-dependent insulinotropic polypeptides GIP1-42 and GIP3-42 from human plasma samples. Journal of Chromatography A. 926(1). 21–27. 28 indexed citations
14.
Pauly, Robert P., Hans‐Ulrich Demuth, Fred Rosche, et al.. (1999). Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide. Metabolism. 48(3). 385–389. 85 indexed citations
16.
Rosche, Fred, et al.. (1996). Reactions of 1,1,3,3-tetrakis(dimethylamino)-1?5,3?5-diphosphete with diphenylchlorophosphane and methyl iodide. Heteroatom Chemistry. 7(5). 341–347. 2 indexed citations
17.
Rosche, Fred, Gernot Heckmann, B. Neumüller, & Ekkehard Fluck. (1996). Übergangsmetall‐Komplexe des 1,1,3,3‐Tetrakis(dimethylamino)‐1λ5,3λ5‐diphosphets. Zeitschrift für anorganische und allgemeine Chemie. 622(6). 942–950. 4 indexed citations
18.
Fluck, Ekkehard, et al.. (1995). Die Reaktion von λ5‐Diphospheten mit COS und CO2 Dihydro‐λ5‐Phosphete. Zeitschrift für anorganische und allgemeine Chemie. 621(9). 1539–1546. 4 indexed citations
19.
Fluck, Ekkehard, Fred Rosche, Gernot Heckmann, & Frank Weller. (1995). 1, 2λ5‐azaphosphinines and a new 1λ5, 3λ5‐. Diphosphinine. Heteroatom Chemistry. 6(4). 355–363. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026